{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:11:52Z","timestamp":1777558312505,"version":"3.51.4"},"reference-count":26,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2012,11,27]],"date-time":"2012-11-27T00:00:00Z","timestamp":1353974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Diabetes and Vascular Disease Research"],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:p>The second Diabetes Glucose and Myocardial Infarction (DIGAMI 2) study randomised patients with diabetes and myocardial infarction to insulin or oral-based treatment. To determine the effects of insulin-based treatment, the Diabetes Treatment Satisfaction Questionnaire (DTSQ) and the Psychological General Well-Being (PGWB) Index were administered at baseline and 12 months. Insulin-treated patients ( n = 197) had a worse risk profile and more co-morbidity at baseline than patients on oral glucose-lowering agents ( n = 127). The treatment satisfaction and psychological well-being was similar between insulin and oral groups at baseline [DTSQ: median (first\u2013third quartile) 30 (24\u201334) vs 31 (27\u201334), NS; PGWB: 77 (73\u201382) vs 79 (76\u201382), NS] and at 12 months [DTSQ: 32 (28\u201335) vs 34 (30\u201336), NS; PGWB: 81 (78\u201384) vs 82 (78\u201384), NS]. Improvement was significant in both groups. Insulin-based therapy was well accepted and did not decrease treatment satisfaction or psychological well-being compared to oral glucose-lowering treatment in patients with type 2 diabetes and myocardial infarction.<\/jats:p>","DOI":"10.1177\/1479164112463711","type":"journal-article","created":{"date-parts":[[2012,11,28]],"date-time":"2012-11-28T00:02:28Z","timestamp":1354060948000},"page":"263-269","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Satisfaction with glucose-lowering treatment and well-being in patients with type 2 diabetes and myocardial infarction: A DIGAMI2 QoL sub-study"],"prefix":"10.1177","volume":"10","author":[{"given":"Laura","family":"Venskutonyte","sequence":"first","affiliation":[{"name":"Cardiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Brismar","sequence":"additional","affiliation":[{"name":"Endocrine and Diabetes Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Ryd\u00e9n-Bergsten","sequence":"additional","affiliation":[{"name":"AstraZeneca, M\u00f6lndal, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Ryd\u00e9n","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbro","family":"Kjellstr\u00f6m","sequence":"additional","affiliation":[{"name":"Cardiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"key":"bibr1-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"bibr2-1479164112463711","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/eurheartj\/ehm124","volume":"28","author":"Ryden L","year":"2007","journal-title":"Eur Heart J"},{"key":"bibr3-1479164112463711","unstructured":"Diabetes Atlas. 5th ed. IDF, http:\/\/www.idf.org\/diabetesatlas\/news\/fifth-edition-release (accessed 25 January 2012)."},{"key":"bibr4-1479164112463711","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.3.447"},{"key":"bibr5-1479164112463711","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-9025"},{"key":"bibr6-1479164112463711","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.7.1535"},{"key":"bibr7-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2007.02279.x"},{"key":"bibr8-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi199"},{"key":"bibr9-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(02)00618-8"},{"key":"bibr10-1479164112463711","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.19.2.142"},{"key":"bibr11-1479164112463711","first-page":"111","volume-title":"Handbook of psychology and diabetes: a guide to psychological measurement in diabetes research and practice","author":"Bradley C","year":"1994"},{"key":"bibr12-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1994.tb00316.x"},{"key":"bibr13-1479164112463711","first-page":"170","volume-title":"Assessment of quality of life in clinical trials of cardiovascular therapies","author":"Dupuy H","year":"1984"},{"key":"bibr14-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90019-1"},{"key":"bibr15-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2004.04.010"},{"key":"bibr16-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.279"},{"key":"bibr17-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2007.03.021"},{"key":"bibr18-1479164112463711","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-2256"},{"key":"bibr19-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-5-8"},{"key":"bibr20-1479164112463711","first-page":"52","volume-title":"Individual quality of life: approaches to conceptualization and assessment","author":"Bech P","year":"1999"},{"key":"bibr21-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-010-0244-y"},{"key":"bibr22-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03329.x"},{"key":"bibr23-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-8-113"},{"key":"bibr24-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-8-86"},{"key":"bibr25-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"bibr26-1479164112463711","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.21.3278"}],"container-title":["Diabetes and Vascular Disease Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1479164112463711","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1479164112463711","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1479164112463711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:22:02Z","timestamp":1777400522000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1479164112463711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,27]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1177\/1479164112463711"],"URL":"https:\/\/doi.org\/10.1177\/1479164112463711","relation":{},"ISSN":["1479-1641","1752-8984"],"issn-type":[{"value":"1479-1641","type":"print"},{"value":"1752-8984","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,27]]}}}